Addendum To Luvox Post

A 350-word addendum to the prior Luvox post: the fluvoxamine team found a way to submit an FDA EUA application without a sponsoring drug company, and the FDA approved Paxlovid two weeks faster than prediction markets expected (6% chance). A brief 'the FDA is genuinely getting better' update.

Quality 50 · Solid. Solid floor: a tiny but substantive follow-up note; near the deep-tail bottom, above pure admin.

Claude’s paradigm shift 25 · Slight. Slight/None: a short update.

Real-world impact 1 · Negligible. Brief update note; negligible material reach. =1.